These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34757678)

  • 1. A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation.
    Becchetti C; Ferrarese A; Zeni N; Russo FP; Senzolo M; Gambato M; Bassi D; Cillo U; Burra P; Germani G
    Clin Transplant; 2022 Feb; 36(2):e14532. PubMed ID: 34757678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcome?
    Herreras López J; Puchades L; Di Maira T; Cañada AJ; Maupoey J; López-Andújar R; Prieto Castillo M; Berenguer Haym M; Aguilera V
    Rev Esp Enferm Dig; 2022 Oct; 114(10):586-591. PubMed ID: 35045717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Predictors of Metabolic Syndrome After Liver Transplantation.
    Vida Perez L; Montero Alvarez JL; Poyato Gonzalez A; Briceño Delgado J; Costan Rodero G; Fraga Rivas E; Barrera Baena P; De la Mata Garcia M
    Transplant Proc; 2016 Sep; 48(7):2519-2524. PubMed ID: 27742339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo metabolic syndrome after liver transplantation: a meta-analysis on cumulative incidence, risk factors, and outcomes.
    Lim WH; Tan C; Xiao J; Tan DJH; Ng CH; Yong JN; Fu C; Chan KE; Zeng RW; Ren YP; Goh XL; Chew N; Tseng M; Syn N; Mak LY; Fung J; Muthiah M; Siddiqui MS; Tan EXX
    Liver Transpl; 2023 Apr; 29(4):413-421. PubMed ID: 36724882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic steatosis after liver transplantation: a systematic review and meta-analysis.
    Silva AC; Nogueira P; Machado MV
    Liver Transpl; 2023 Apr; 29(4):431-448. PubMed ID: 36735478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation.
    Andrade AR; Bittencourt PL; Codes L; Evangelista MA; Castro AO; Sorte NB; Almeida CG; Bastos JA; Cotrim HP
    Ann Hepatol; 2017 November-December,; 16(6):932-940. PubMed ID: 29055928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is everolimus linked to metabolic syndrome in liver transplant recipients?
    Cholongitas Ε; Koukoufiki A; Pipili C; Antoniadis N; Fouzas I; Haidich AB; Goulis I
    Indian J Gastroenterol; 2019 Aug; 38(4):348-355. PubMed ID: 31515763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome after a liver transplantation in an Asian population.
    Tan HL; Lim KB; Iyer SG; Chang SK; Madhavan K; Kow AW
    HPB (Oxford); 2015 Aug; 17(8):713-22. PubMed ID: 26172138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight Gain and
    Lattanzi B; D'Ambrosio D; Tavano D; Pitoni D; Mennini G; Ginanni Corradini S; Rossi M; Merli M
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31835505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
    Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M
    Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis.
    Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J
    Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular morbidity and mortality is increased post-liver transplantation even in recipients with no pre-existing risk factors.
    De Luca L; Kalafateli M; Bianchi S; Alasaker N; Buzzetti E; Rodríguez-Perálvarez M; Thorburn D; O'Beirne J; Patch D; Leandro G; Westbrook R; Tsochatzis EA
    Liver Int; 2019 Aug; 39(8):1557-1565. PubMed ID: 31233663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Analysis of Metabolic Parameters in the Detection of Diabetes and Metabolic Syndrome in Liver Transplant Recipients.
    Kahn A; Reynolds JA; Chakkera HA; Aqel BA; Byrne TJ; Douglas DD; Moss AA; Vargas HE; Carey EJ
    Metab Syndr Relat Disord; 2016 Aug; 14(6):305-10. PubMed ID: 27164306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil.
    D'Avola D; Cuervas-Mons V; Martí J; Ortiz de Urbina J; Lladó L; Jimenez C; Otero E; Suarez F; Rodrigo JM; Gómez MA; Fraga E; Lopez P; Serrano MT; Rios A; Fábrega E; Herrero JI
    Liver Transpl; 2017 Apr; 23(4):498-509. PubMed ID: 28160394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
    Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD
    Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.
    Sérée O; Altieri M; Guillaume E; De Mil R; Lobbedez T; Robinson P; Segol P; Salamé E; Abergel A; Boillot O; Conti F; Chazouillères O; Debette-Gratien M; Debray D; Hery G; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Jacquemin E; Kamar N; Latournerie M; Lebray P; Leroy V; Mazzola A; Neau-Cransac M; Pageaux GP; Radenne S; Saliba F; Samuel D; Vanlemmens C; Woehl-Jaegle ML; Launoy G; Dumortier J
    Liver Transpl; 2018 Oct; 24(10):1425-1436. PubMed ID: 30021061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
    Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
    Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hypertension after living-donor liver transplantation: a prospective study.
    Tong MS; Chai HT; Liu WH; Chen CL; Fu M; Lin YH; Lin CC; Chen SM; Hang CL
    Transplant Proc; 2015 Mar; 47(2):445-50. PubMed ID: 25769588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.
    Stepanova M; Henry L; Garg R; Kalwaney S; Saab S; Younossi Z
    BMC Gastroenterol; 2015 Dec; 15():175. PubMed ID: 26666336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
    Mouchli MA; Singh S; Boardman L; Bruining DH; Lightner AL; Rosen CB; Heimbach JK; Hasan B; Poterucha JJ; Watt KD; Kane SV; Raffals LE; Loftus EV
    Inflamm Bowel Dis; 2018 Apr; 24(5):1074-1081. PubMed ID: 29522202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.